Model
Edge
4D Molecular Therapeutics
0001881504
Filing Type
3
Filing Date
9/25/2023
Updated
9/26/23, 3:33 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership